Year: 2023

LUXEMBOURG, Oct. 26, 2023 (GLOBE NEWSWIRE) — Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the third quarter 2023. “I am pleased with our third quarter performance.  We generated $874 thousand of Adjusted EBITDA(2), a $4.4 million improvement over the second quarter of 2023 and a $7.3 million improvement over the same quarter in 2022.  For the first nine months of 2023, we improved Adjusted EBITDA by $16.1 million compared to the same period last year.  We also generated $18.4 million in net proceeds from the September sale of equity and used $10 million of the proceeds to reduce the principal balance of our term loan.   As a result of the debt reduction, we eliminated 966,038...

NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) — Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today reported net income for the third quarter 2023 of $141.3 million, or $0.27 per diluted common share, as compared to the second quarter 2023 net income of $139.1 million, or $0.27 per diluted common share, and net income of $178.1 million, or $0.34 per diluted common share, for the third quarter 2022. Excluding all non-core income and charges, our adjusted net income (a non-GAAP measure) was $136.4 million, or $0.26 per diluted common share, for the third quarter 2023, $147.1 million, or $0.28 per diluted common share, for the second quarter 2023, and $181.5 million, or $0.35 per diluted common share, for the third quarter 2022. See further details below, including a reconciliation of our non-GAAP...

NEWARK, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2023 with the following highlights:Sales of $39.5 million representing an 18.8% year-over-year increase Operating income of $2.1 million versus a loss of $0.6 million for the 2022 third quarter Adjusted EPS of $0.10 compared to a loss of $0.03 for the 2022 third quarter Adjusted EBITDA of $3.5 million representing a 177.3% year-over-year increase Backlog of $101.1 million exiting the 2023 third quarter“Driven by continuing strong demand from our government/defense and medical customers, sales grew 19% for both the 2023 third quarter and the first nine months to $39.5 million and $114.1 million, respectively, over the prior year periods. We continue to focus on recapturing gross...

WOBURN, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the quarter and nine month period ended September 30, 2023. The Company’s mission is to reduce the impact of neurological disorders and pain syndromes through innovative non-invasive medical devices. “We continue to be encouraged by the market response to Quell® Fibromyalgia during its strategic launch. We now have field sales capabilities in the key markets of Texas, Florida and California,” said Shai N. Gozani, M.D., Ph.D., Chief Executive Officer of NeuroMetrix. “We intend to further expand our physician sales capabilities to support Quell Fibromyalgia growth and to position the launch of the next Quell disease indication, likely chemotherapy induced peripheral neuropathy (CIPN). Dr....

Third quarter 2023 earnings per share of $1.05 increases 62% year-over-year and 11% sequentially Despite the Illinois River closure, inland marine experienced strong market conditions with a sequential increase in spot market prices and high-teens operating margins Distribution and services 2023 third quarter operating income improved 49% year-over-year and 11% sequentially   Kirby repurchased 290,255 shares at an average price of $80.31 for $23.3 millionHOUSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) — Kirby Corporation (“Kirby”) (NYSE: KEX) today announced net earnings attributable to Kirby for the third quarter ended September 30, 2023 of $63.0 million or $1.05 per share, compared with earnings of $39.1 million, or $0.65 per share for the 2022 third quarter. Consolidated revenues for the 2023 third quarter were $764.8 million...

MATTOON, Ill., Oct. 26, 2023 (GLOBE NEWSWIRE) — First Mid Bancshares, Inc. (NASDAQ: FMBH) (the “Company”) today announced its financial results for the quarter ended September 30, 2023. HighlightsNet income of $15.1 million, or $0.68 diluted EPS Adjusted net income (non-GAAP) of $17.1 million, or $0.77 diluted EPS Closed on the acquisition of Blackhawk Bancorp, Inc. (“Blackhawk”) on August 15th Completed balance sheet restructuring by selling a portion of Blackhawk bonds Increased liquidity position and lowered loan to deposit ratio to 87% Net interest margin, on a tax equivalent basis (non-GAAP), improved to 3.06% for the third quarter“We are pleased to deliver solid core results that provide a baseline to the earnings momentum we expect to achieve with the Blackhawk acquisition,” said Joe Dively, Chairman and Chief Executive...

PORT ANGELES, Wash., Oct. 26, 2023 (GLOBE NEWSWIRE) — Matthew P. Deines, President and CEO, comments on financial results: “The Company continues to manage through this historic interest rate environment by remaining focused on deepening existing relationships and acquiring new customers,” said Matthew P. Deines, President and CEO. “We are also maintaining our commitment to reducing non-interest expense, which bore out in lower operating expenses and an improved efficiency ratio this quarter compared to the linked quarter. We celebrated our 100th anniversary in style during the quarter at an event in Port Angeles, which highlighted our history, strength and commitment to our communities. We also enjoyed great music, culture and food with friends and family.” The Board of Directors of First Northwest Bancorp...

ENGLEWOOD CLIFFS, N.J., Oct. 26, 2023 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of $19.9 million for the third quarter of 2023, compared to $19.9 million for the second quarter of 2023 and $27.4 million for the third quarter of 2022. Diluted earnings per share were $0.51 for the third quarter of 2023, $0.51 for the second quarter of 2023 and $0.70 for the third quarter of 2022. The decreases in net income available to common stockholders and diluted earnings per share from the third quarter of 2022 were primarily due to a $15.8 million decrease in net interest income and a $3.6 million increase in noninterest expenses, partially offset by an $8.5 million decrease in the provision...

Net Revenue up 72% to $23.4 Million vs. Q3 2022 Net Loss Decreased by 74% to $1.4 Million vs. Q3 2022 Adjusted EBITDA of $5.4 Million in Q3 2023 Successful Integration of YUTIQ into the U.S. SegmentATLANTA, Oct. 26, 2023 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the third quarter of 2023. Alimera will host a conference call today at 9:00 a.m. EDT to discuss these results. “We are pleased to announce record net revenue of $23.4 million, a significant decrease in our net loss and record Adjusted EBITDA in our first full quarter selling both ILUVIEN and YUTIQ,” said Rick Eiswirth, Alimera’s President...